Cardio-protection includes" all mechanism and means that contribute to the preservation of the heart by reducing or even preventing Myocardial damage. Cardiovascular disease (CVD) remains the principle cause of death in both developed and developing countries. It may present as a typical heart attack, a sudden death or it may be detected at an advanced stage and be described as a silent infarct. CVD includes high blood pressure, coronary heart disease, congestive heart failure, stroke and accounts Myocardial infarction is the interruption of blood supply to part of the heart, causing heart cells to die, commonly due to blockage of coronary artery. Herbal drugs are known to exhibit creditable medicinal properties for the treatment of heart ailments and need to be explored to identify their potential application in prevention and therapy of human ailments. Cardio-vascular disease remains a leading cause of death in India. Therefore, finding ways to reduce the mortality of cardiovascular disease remains an important health goal. This review deals with medicinal plants possessing cardioprotective and cardio tonic activity. Cardiovascular disease is the number one cause of death globally and is projected to remain the leading cause of death. This review work explains chemical and pharmacological status of various cardio-protective plants including phyto constituents responsible for cardio-protection, extract employed, dosage, pharmacological screening model and mechanism involved in cardio-protection. This review work definitely helps in enlisting the Indian plants having cardioprotective activity.
INTRODUCTION
The medicinal plants are potential sources of drugs as they are rich in secondary metabolites and essential oils of therapeutic importance. 1 Uses of medicinal plants in various ailments are due to being economical, effective, their ease availability and due to their safety. 2 Because of these advantages the use of medicinal plants has been widely increased by the traditional medical practitioners in their day to day practice. 3 Foods are used commonly to meet our nutritional needs. However, foods obtained by plants contain a wide range of non-nutrient phytochemicals that are synthesized by plants for their own defence and for other biological functions. When we ingest these plant foods to meet our nutritional needs, we also ingest a wide variety of these non-nutrient phytochemicals. These phytochemicals have the potential for preventing chronic diseases and also non-toxic. 4 Cardiovascular disease is the number one cause of death globally and is projected to remain the leading cause of death. As many as 1.4 million children are suffering from heart related diseases in Pakistan and some 8,000 need heart surgeries annually, but out of them only 1,200 are operated upon. (Sixth "Biennial International Conference, " organized by the Pakistan Society of Cardiovascular and Thoracic Surgeries). Free radicals play deleterious role to body established ischemia. Presence of various antioxidant compounds in fruits and vegetables, for example, vitamins C and E, b-carotene and polyphenolics have been associated with decreased risks of several chronic diseases, such as coronary heart disease and some cancers. Antioxidants scavenging the free radicals and protect the body. There is inverse relationship between intake of polyphenols and heart diseases. 5 There is a large and increasing global burden of cardiovascular disease. Approximately 14 million individuals died of cardiovascular disease in 1990, and this is projected to rise to about 25 million by 2020. 6 The global burden of disease due to cardiovascular diseases (CVDs) is escalating, principally due to a sharp rise in the developing countries which are experiencing rapid health transition. 7 The continuous increase in incidences of cardiovascular disease is a manifestation of chronic poor diet and lifestyle choices, which lead to diabetes and obesity. 8 More than 2000 plants have been listed in the Traditional (Herbal/Alternative) systems of medicine and some of these are providing comprehensive relief to the people suffering from cardio-vascular diseases, specially "hyperlipidemia" and "ischemic heart disease". WHO reports indicate that around eighty percent of the global population still relies on botanical drugs and several herbal medicines have advanced to clinical use in modern times. The use of Western medicinal drugs for the treatment of hypertension, congestive heart failure and post myocardial infarction are widely accepted. 9 Various phytoconstituents from plants were responsible for cardioprotective activity. Refer Table 1 .
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METHODS EMPLOYED
Pharmacology of cardioprotective plants: Phytoconstituents reported in cardioprotective plants significantly prevented the altered biochemical variation such as marker enzymes serum glutamate-pyruvate transaminase (SGPT) or alanine transaminase (ALT), serum glutamate oxaloacetate transaminase (SGOT) or aspartate transaminase (AST), creatinephosphokinase (CPK), alkaline phosphatise (ALP), lactate dehydrogenase (LDH), lipid profile including low density lipoprotein (LDL), VLDL (very low density lipoprotein), triglycerides (TGs), high density lipoprotein (HDL), total cholesterol and antioxidant parameters including Superoxide dismutase (SOD), glutathione (GSH), catalase (CAT), Glutathione peroxidase (GPx), MDA (malonaldialdehyde) and glutathione reductase (GR) come to near normal status. Cardioprotective activity was evaluated using various pharmacological screening models like isoprenaline induced myocardial necrosis in rats, doxorubicin (DOX) induced cardiotoxicity in albino rats, cyclophosphamide induced oxidative myocardial injury in a rat model, ischemia-reperfusion-induced myocardial infarction in albino rats, cigarette Smoke-exposed Rats, adriamycin-induced cardio Myopathy in rats etc. 
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CONCLUSION
Secondary metabolites like carotenoids, triterpenes, flavonoids, cardiac glycosides, alkaloids saponins, polyphenols, terpenoids, fatty acids etc were responsible for cardio-protective activity at a particular dose which was evaluated using appropriate pharmacological screening approach.
